MENU
BLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioLineRx (BLRX) Ownership - Who owns BioLineRx?
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.02M
P/E Ratio
N/A
Total Cash
28.16M
Projected Growth
N/A
Total Debt
12.6M
Revenue
17.25M
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
6.61
Total Debt/Equity
N/A
Revenue/Share
5.83 USD as % of share price
Fundamentals
BLRX
Capitalization
16M
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
28.2M
Total Cash/Share
6.61
Total Debt
12.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.83%
Revenue
17.3M
ROE
N/A
Book Value
20.1M
P/B Ratio
0.78
Cash Flow
N/A
Earnings
-6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
71.8M
Current Ratio
2.06
Current Revenue Per Employee
10857.14
Dividends Per Share - Security
N/A
EBITDA
1.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
76.32
Revenue To Assets
-14.50
Shares Held By Institutions
40.3K
Shares Outstanding - Current
4.26M
Total Liabilities
23.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-57.360
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical development company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com